Therapy for severe vasculitis shows long-term effectiveness




Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.

Fuente : http://www.eurekalert.org/pub_releases/2013-07/nio...

Miércoles, 31 de Julio 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección